| Literature DB >> 24204358 |
Isidro Martinez-Cascales1, Juanma de la Fuente, Julio Santiago, Julio Santiago.
Abstract
As a test of the idea of a common brain system responsible for representing all prothetic dimensions, schizophrenic patients and healthy participants took part in a line bisection task and two visual temporal bisection tasks, one using durations from 1 to 4 s and another using 30 s long specially designed stimuli (aging faces). Against expectations, schizophrenics showed better precision (smaller variable error) both in line bisection and the aging faces temporal task than healthy controls. Moreover, patients also showed less bias (smaller constant error) than controls in the aging faces task. This increased precision correlated with degree of severity of schizophrenia. Although no group differences were found in the temporal task with shorter intervals, both variable and constant error measures correlated marginally with severity of schizophrenia, also in the direction of smaller error in more severe cases. Thus, overall, spatial and temporal tasks behaved similarly across groups. However, bias and precision indexes did not covary across the three tasks when correlations where computed over the whole set of participants in the present study. The results thus provide mixed support for a common system behind spatial and temporal processing and point toward the need of developing a more nuanced view of magnitude representation in the mind/brain.Entities:
Keywords: bisection tasks; common coding; schizophrenia; space; time
Year: 2013 PMID: 24204358 PMCID: PMC3817397 DOI: 10.3389/fpsyg.2013.00823
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
Figure 1Three frames extracted from initial, middle, and final moments in one of the video clips of the Aging Faces task.
Figure 2Proportion of trials with “end” response as a function of temporal position in the video clip in the Aging Faces task in Experiment 1 (healthy participants).
Demographic and clinical variables of participants in Experiment 1.
| Control | Female | 36 | Right | 13 | – | – | – | – | – | – | – | – | ||
| Control | Male | 22 | Right | 12 | – | – | – | – | – | – | – | – | ||
| Control | Male | 40 | Right | 8 | – | – | – | – | – | – | – | – | ||
| Control | Male | 27 | Right | 8 | – | – | – | – | – | – | – | – | ||
| Control | Female | 35 | Right | 13 | – | – | – | – | – | – | – | – | ||
| Control | Male | 30 | Left | 12 | – | – | – | – | – | – | – | – | ||
| Control | Female | 43 | Right | 12 | – | – | – | – | – | – | – | – | ||
| Control | Male | 31 | Right | 8 | – | – | – | – | – | – | – | – | ||
| Control | Male | 40 | Right | 8 | – | – | – | – | – | – | – | – | ||
| Control | Male | 45 | Right | 8 | – | – | – | – | – | – | – | – | ||
| Control | Male | 28 | Right | 9 | – | – | – | – | – | – | – | – | ||
| Control | Female | 25 | Right | 9 | – | – | – | – | – | – | – | – | ||
| Patient | Female | 36 | Right | 12 | Schizophrenia—paranoid | 295.30 | 11 | 16 | 43 | 70 | 12 | 50 | 861 | Paliperidone, Ziprasidone, Risperidone |
| Patient | Female | 32 | Right | 8 | Schizophrenia—paranoid | 295.30 | 24 | 26 | 44 | 93 | 7 | 42 | 100 | Topiramate, Levomepromazine maleato |
| Patient | Male | 25 | Right | 6 | Schizophrenia—paranoid, mental retardation | 295.30, 317 | 16 | 24 | 39 | 79 | 11 | 44 | 1033 | Paliperidone, Amisulpride, Levomepromazine maleato |
| Patient | Male | 30 | Right | 5 | Schizophrenia—paranoid | 295.30 | 17 | 31 | 42 | 90 | 10 | 46 | 700 | Amisulpride, Levomepromazine maleato |
| Patient | Male | 45 | Right | 12 | Schizophrenia—paranoid | 295.30 | 25 | 18 | 39 | 82 | 5 | 52 | 456 | Zuclopenthixol decanoate, Ziprasidone |
| Patient | Male | 48 | Right | 7 | Schizophrenia—paranoid | 295.30 | 24 | 22 | 34 | 80 | 6 | 50 | 220 | Paliperidone |
| Patient | Male | 45 | Right | 8 | Schizophrenia—paranoid | 295.30 | 23 | 23 | 32 | 78 | 9 | 36 | 596 | Risperidone, Fluphenazine decanoate |
| Patient | Female | 38 | Right | 12 | Schizoafective disorder | 295.70 | 19 | 21 | 45 | 85 | 3 | 52 | 0 | Lithium carbonate, Escitalopram oxalate |
| Patient | Female | 33 | Left | 12 | Schizophrenia—disorganized | 295.10 | 22 | 19 | 38 | 79 | 4 | 44 | 775 | Quetiapine fumarate, Ziprasidone |
| Patient | Male | 39 | Right | 11 | Schizophrenia—paranoid | 295.30 | 14 | 19 | 30 | 63 | 1 | 50 | 376 | Ziprasidone, Clozapine |
| Patient | Female | 31 | Right | 10 | Schizoafective disorder | 295.70 | 14 | 19 | 28 | 61 | 8 | 48 | 800 | Clotiapine, Clonazepam |
| Patient | Male | 41 | Right | 12 | Schizophrenia—paranoid | 295.30 | 19 | 20 | 34 | 73 | 2 | 56 | 1067 | Clozapine, Amisulpride, Aripripazole |
Education level is coded as number of schooling years since age 6. For each patient, the following information is presented: (1) scores obtained in the three subscales (Positive, Negative, General Psychopathology) of the Positive and Negative Syndrome Scale (Kay et al., 1987), as well as its total score; (2) the Global Assessment of Functioning (GAF; DSM-IV-TR, 2000); (3) the Severity Rank (see description in main text); (4) Medication, in DCI names; and (5) Chlorpromazine equivalents for the medication and dosage of each patient. The following conversion rates were used (in mgr/day equivalents to a dosis of 100 mgr/day of chlorpromazine): Amisulpride (100)a, Aripripazole (7.5)a, Clotiapine (10)b, Clozapine (100)a, Fluphenazine decanoate (2)c, Levomepromazine maleato (100)a, Paliperidone (1.5)d, Quetiapine fumarate (77)a, Risperidone (1.5)a, Ziprasidone (62.5)a, Zuclopenthixol decanoate (14.3)a. The superscript in each drug refers to the source where equivalent doses were obtained from: (a) Kroken et al. (2009); (b) Tibaldi et al. (1997); (c) Atkins et al. (1997); (d) Woods (2011).
Figure 3Bias and precision indexes in one spatial (Line Bisection) and two temporal (Standard Time Bisection and Aging Faces Bisection) tasks. Bias (constant error) and precision (standard deviation) in Line Bisection are expressed in millimetres. Bias (PSE) and precision (JND) in both the Standard Time Bisection and the Aging Faces tasks are expressed in arbitrary units from 0 to 10 where 0 is the beginning and 10 the end of the stimulus. Error bars represent standard error of the mean.
Figure 4Significant and marginal correlations including only the group of schizophrenic patients between the Chlorpromazine index (Chlorpro) and performance indexes, with best-fitting regression line and 95% confidence intervals. The two upper scatterplots are significant correlations with precision in Line Bisection (left) and bias in Aging Faces (right). The two lower scatterplots are marginally significant correlations with bias in Standard Time Bisection (left) and precision in Standard Time Bisection (right).